125 related articles for article (PubMed ID: 2068131)
1. Inverse expression of MYCN and mdr-1 in human neuroblastoma.
Nakagawara A; Kadomatsu K; Sato S; Kohno K; Takano H; Kuwano M
Prog Clin Biol Res; 1991; 366():11-9. PubMed ID: 2068131
[No Abstract] [Full Text] [Related]
2. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis.
Nakada K; Fujioka T; Kitagawa H; Takakuwa T; Yamate N
Jpn J Clin Oncol; 1993 Jun; 23(3):149-55. PubMed ID: 8350488
[TBL] [Abstract][Full Text] [Related]
3. Competitive polymerase chain reaction for the determination of N-myc amplification in neuroblastoma: report of clinical cases.
Hasan Z; Inoue A; Ikeda H; Kamii Y; Obana K; Yokomori K; Tsuchida Y; Hemmi H; Shimatake H
Eur J Pediatr Surg; 1999 Jun; 9(3):138-41. PubMed ID: 10427487
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of N-myc oncogene amplification and S-100 protein positivity in children with neuroblastic tumors.
Hachitanda Y; Nakagawara A; Nagoshi M; Tsuneyoshi M
Acta Pathol Jpn; 1992 Sep; 42(9):639-44. PubMed ID: 1476058
[TBL] [Abstract][Full Text] [Related]
5. [The morphology of tumors of the sympathetic nervous system].
Dikshteĭn EA; Beniashvili DSh
Vopr Onkol; 1969; 15(9):22-8. PubMed ID: 5354745
[No Abstract] [Full Text] [Related]
6. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
7. Expression of MDR1 and GST pi genes in 35 advanced neuroblastomas.
Bourhis J; Hartmann O; DeVathaire F; Terrier-Lacombe MJ; Boccon-Gibod L; Lemerle J; Riou G; Bénard J
Prog Clin Biol Res; 1991; 366():127-34. PubMed ID: 2068133
[No Abstract] [Full Text] [Related]
8. Determination of genomic damage in neuroblastic tumors by arbitrarily primed PCR: MYCN amplification as a marker for genomic instability in neuroblastomas.
Muñoz J; Vendrell E; Aiza G; Nistal M; Pestaña A; Peinado MA; Castresana JS
Neuropathology; 2006 Jun; 26(3):165-9. PubMed ID: 16771170
[TBL] [Abstract][Full Text] [Related]
9. Stage IVS neuroblastoma: a clinical, histological, and biological analysis of 45 cases.
Hachitanda Y; Hata J
Hum Pathol; 1996 Nov; 27(11):1135-8. PubMed ID: 8912820
[TBL] [Abstract][Full Text] [Related]
10. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.
Nakagawara A; Kadomatsu K; Sato S; Kohno K; Takano H; Akazawa K; Nose Y; Kuwano M
Cancer Res; 1990 May; 50(10):3043-7. PubMed ID: 2185879
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity on chromosome 14 in neuroblastoma.
Suzuki T; Mugishima H; Fujisawa T; Okuni M; Okabe I; Yokota J; Terada M
Prog Clin Biol Res; 1991; 366():135-45. PubMed ID: 2068134
[No Abstract] [Full Text] [Related]
12. [Molecular genetic abnormalities of N-myc and C-myc in pediatric neuroblastic tumors and clinical pathologic significance].
Cai RQ; Zhou CJ; Sun QN; Ma XL; Wang M; Li Y; Wang DY; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):299-304. PubMed ID: 24004585
[TBL] [Abstract][Full Text] [Related]
13. [Familial neuroblastoma of the suprarenal glands in the newborn (author's transl)].
Klein H; Plöchl E
MMW Munch Med Wochenschr; 1974 Jun; 116(23):1163-8. PubMed ID: 4212656
[No Abstract] [Full Text] [Related]
14. [Morphology of experimental tumors of the sympathetic nervous system].
Beniashvili DSh
Arkh Patol; 1979; 41(6):20-4. PubMed ID: 464834
[TBL] [Abstract][Full Text] [Related]
15. [Transformation of neuroblastoma into ganglioneuroma. Presentation of 2 cases].
Arap S; Novaretti JP; Srougi M; Defiori FF; Menezes de Góes G
Arch Esp Urol; 1982; 35(2):125-30. PubMed ID: 7114908
[No Abstract] [Full Text] [Related]
16. N-myc amplification in neuroblastomas: histopathological, DNA ploidy, and clinical variables.
Oppedal BR; Oien O; Jahnsen T; Brandtzaeg P
J Clin Pathol; 1989 Nov; 42(11):1148-52. PubMed ID: 2584426
[TBL] [Abstract][Full Text] [Related]
17. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B
Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595
[TBL] [Abstract][Full Text] [Related]
18. Detection of N-myc amplification in neuroblastomas using Southern blotting on fine needle aspirates.
Barroca H; Carvalho JL; da Costa MJ; Cirnes L; Seruca R; Schmitt FC
Acta Cytol; 2001; 45(2):169-72. PubMed ID: 11284301
[TBL] [Abstract][Full Text] [Related]
19. Neuroblastoma in monozygotic twins with distinct presentation pathology and outcome: is it familial or in utero metastasis.
Abu-Arja R; Hashem H; El-Sheikh A; Abusin G
Pediatr Blood Cancer; 2014 Jun; 61(6):1124-5. PubMed ID: 24376049
[TBL] [Abstract][Full Text] [Related]
20. Chromosome findings and prognosis in 15 patients with neuroblastoma found by VMA mass screening.
Hayashi Y; Inaba T; Hanada R; Yamamoto K
J Pediatr; 1988 Apr; 112(4):567-71. PubMed ID: 3351679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
